drugset / Trial / NCT00653016

An Open-label, Multicentre Study on Preference and Satisfaction of Canadian Women for the Transdermal Contraceptive Patch vs. Previous Primary Contraceptive Method

NCT00653016

Phase 4 Completed 405 enrolled Janssen-Ortho Inc., Canada
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to document the experience of transdermal contraceptive patch over a period of 9 cycles, compared to their previous contraceptive method.

Timeline

Start
2002-10
Primary completion
Completion
2003-08

Drugs

EvaluationDrugModalityDoseRoute
Subject ethinyl estradiol Small molecule 20 ug Other
Subject norelgestromin Unknown 150 ug Other

Indications

No indication recorded.